Showing results (51-60 of 72) with videos related to
Sort By:
Pageof 8
American Journal of Physiology. Renal Physiology|February 17, 2012
Nicorandil as a novel therapy for advanced diabetic nephropathy in the eNOS-deficient mouseKatsuyuki Tanabe, Miguel A Lanaspa, Wataru Kitagawa, et al.Journal of Diabetes|September 1, 2019
Fructose tolerance test in obese people with and without type 2 diabetesEbaa Al-Ozairi, Christopher J Rivard, Laura Gabriela Sanchez Lozada, et al.Lung Cancer (Amsterdam, Netherlands)|June 5, 2017
Therapy-induced E-cadherin downregulation alters expression of programmed death ligand-1 in lung cancer cellsKenichi Suda, Leslie Rozeboom, Christopher J Rivard, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 24, 2014
Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: evolutionary implications of the uricase loss in hominidsChristina Cicerchi, Nanxing Li, James Kratzer, et al.Pediatric Nephrology (Berlin, Germany)|May 22, 2013
Serum from minimal change patients in relapse increases CD80 expression in cultured podocytesTakuji Ishimoto, Gabriel Cara-Fuentes, Heiman Wang, et al.Journal of Surgical Oncology|January 31, 2022
Loss of STING expression is prognostic in non-small cell lung cancerZoltan Lohinai, David Dora, Charles Caldwell, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 28, 2011
Toll-like receptor 3 ligands induce CD80 expression in human podocytes via an NF-κB-dependent pathwayMichiko Shimada, Takuji Ishimoto, Pui Y Lee, et al.Lung Cancer (Amsterdam, Netherlands)|November 16, 2018
The immune checkpoint, HVEM may contribute to immune escape in non-small cell lung cancer lacking PD-L1 expressionShengxiang Ren, Qinrui Tian, Nadav Amar, et al.Plos One|November 16, 2012
Counteracting roles of AMP deaminase and AMP kinase in the development of fatty liverMiguel A Lanaspa, Christina Cicerchi, Gabriela Garcia, et al.Clinical Lung Cancer|August 28, 2018
A miRNA Panel Predicts Sensitivity of FGFR Inhibitor in Lung Cancer Cell LinesShengxiang Ren, Christopher J Rivard, Hui Yu, et al.Pageof 8